Navigation Links
Marken Announces Its New Logistics Operating System: Maestro™
Date:12/13/2011

LONDON, Dec. 13, 2011 /PRNewswire/ -- Marken announced today that it has significantly upgraded its existing operating system with centralized web-based application exclusively designed for its growing supply chain organization.  The system, known as 'Maestro' has an innovative flexible architecture which will enable extensive tracking of shipments, integrated documentation, client reporting and performance monitoring.  It is designed explicitly for ease of integration with client's systems to meet their growing requirements with temperature and time sensitive drugs to be shipped worldwide. Its interfaces and flexible structure enables each of its clients to input and track relevant data connected with a clinical trial and manage the hand-offs between shipments from site to lab and country to country.  This new operating system, when coupled with Marken's new Solo™ system for its depot operations, will allow Marken to manage the complete inbound and outbound cycle for clinical trials.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"We are very proud to announce the new Maestro system to our clients," said Cyril Leger, Chief Operating Officer, Marken.  "We have been working on this new system for many months and have incorporated our best thinking as well as feedback from our clients.  Our customer service representatives can now work more efficiently around the clock, across all of our 24 branch locations, and track shipments more precisely than ever before."

"We at Marken are committed to continuing our journey towards perfection in supply chain management," said Wes Wheeler, CEO, Marken. "We know how important it is to be trusted with our clients' proprietary drugs, kits and samples.  Time is critical in the race for new drug treatments and we want to play our part, whatever it takes."

About Marken

Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates depot and logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

 


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
2. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
3. Marken Rapidly Responds to Global Supply Chain Security Measures
4. Marken Unveils New Japan Office
5. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
6. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
7. Stereotaxis Announces Initial Shipments of the Epoch™ Platform to Customers
8. Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted
9. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
10. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
11. SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):